Luminary Therapeutics, Inc.
Amendment
CIK: 0001793860·Biotechnology·DELAWARE·Filed: Aug 3, 2023
Total Offering
$3,500,000
Amount Sold
$2,379,500
Investors
12
First Sale
Sep 28, 2022
Offering Details
- Type
- Equity, Other: SAFE (Simple Agreement Future Equity)
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2019
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Jeff Liter | Related Person |
| John Hurley | Related Person |
| David Largaespada | Related Person |
| John Wells | Related Person |
| James Haymaker | Related Person |
| Tracey Lodie | Related Person |
| Alexander Naydich | Related Person |
| Mark Chance | Related Person |
Company
SEC Filing
0001437749-23-021823
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free